The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback